Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab

Currently, there are few effective therapies for locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC); however, there is recent evidence supporting the use of immunological therapies in cSCC given the typically high mutation burden and association with immunosuppressed states. Th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Venkatesh, Samantha, Al-Haseni, Ali, Sahni, Debjani
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019
Gaiak:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6685369/
https://ncbi.nlm.nih.gov/pubmed/31377718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229915
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak